NCT06057857 is a clinical trial of conventional oral examination in Oral Cancer, sponsored by Cairo University.

Who is sponsoring NCT06057857?

NCT06057857 is sponsored by Cairo University.

What drugs are being tested in NCT06057857?

Interventions in NCT06057857: conventional oral examination.

What condition does NCT06057857 study?

NCT06057857 studies Oral Cancer.

Is NCT06057857 still recruiting?

NCT06057857 is currently completed. Last updated 28 September 2023.

Last reviewed 2023-09-28 · How we verify

NCT06057857

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oral Cancer Screening in Workplace: a Cross-sectional Study

Completed Last updated 28 September 2023

What this trial tests

trial testing conventional oral examination in Oral Cancer in 302 participants. Completed in 1 April 2023.

Timeline

1 February 2023

Primary endpoint
30 March 2023

1 April 2023

Quick facts

Lead sponsor	Cairo University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	302
Start date	1 February 2023
Primary completion	30 March 2023
Estimated completion	1 April 2023
Sites	1 location across Egypt

Drugs / interventions tested

conventional oral examination

Conditions studied

Oral Cancer — all drugs for Oral Cancer →

Sponsor

Cairo University

Who can join

18 and older, any sex, with Oral Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Employees are to be all screened for oral cancer in work place.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Oral Cancer

Currently open trials in the same condition.

NCT07509619 — AI-based Physiotherapy Evaluation System for Range of Motion in Oral Cancer Patients · recruiting
NCT07260344 — Evaluation of Two Non-Invasive Methods, High-Resolution Microendoscopy and Liquid-Based Cytology, for Detection of Oral · NA · recruiting
NCT06682494 — Enhancing Oral Cancer Awareness · NA · recruiting
NCT07095608 — Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain · NA · recruiting
NCT07296250 — Circulating Tumor Cell Counts in Postoperative ENE-Positive Oral Cavity Cancer Patients After Adjuvant CCRT · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06057857 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 28 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06057857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing